Showing posts with label Nimesulide actions. Show all posts
Showing posts with label Nimesulide actions. Show all posts

Friday, November 21, 2014

Nimesulide Tablet Formulation

Nimesulide, a widely prescribed anti-inflammatory analgesic drug belongs to BCS class II and exhibit low and variable oral bioavailability.
 
Nimesulide (4-nitro-2-phenoxymethanesulfoanilide) may be a particular Cox-2 anti-inflammatory medication. This compund, a by-result of p-nitrophenyl methane arrangement sulfa, is structurally a solitary non-steroidal anti-inflammatorydrug. It has a place with particular COX-2inhibitors, with an intense pain relieving movement.

its shown as second line treatment for  acute pain, symptomatic treatment of excruciating degenerative joint ailment and first dysmenorrhoea.
Nimesulide tablet incorporates:
  • Fast results
  • Helpful and supportive
  • No feature impacts
  • Fast and quick effects
Nimesulide Tablet Advantages:
  • Nimesulide has less gastrointestinal adverse effects than other NSAIDs
  • It has superior benefit-risk ratio to other drugs with a comparable safety and tolerability to placebo.
  • Its multifactorial mode of action gives it a unique and broad action on inflammatory.
  • Nimesulide is also safe in sensitive asthmatic patients. It is reported to be beneficial in relieving the symptoms of rhinitis, rhinopharyngitis tubaritis and seceretory otitis media with concomitant antibiotic treatment. 
  • Nimesulide has potent analgesic, anti-inflammatory and antipyretic activities

Wednesday, September 10, 2014

nimesulide 100mg drug interactions

Nimesulide is a leading NSAID’S drug with anti-inflammatory agent that differs from conventional nonsteroidal anti-inflammatory drugs both in structure and pharmacological profile.

Its main purpose is to treat acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea .

Nimesulide Tablet shows the result from pain within 15min from the drug intake

Nimesulide is available in the from of tablet, capsule and gel with the dosage of 100mg. Nimesulide is preffered for the shortest duration to minimize the risk of hepatotoxicity.

NImesulide tablet has a properties of analgesic (pain relief)and antipyretic (reduction of body temperature) 

The use of nimesulide in children under the age of 12 is contraindicated. Continuous use of nimesulide (more than 15 days) can cause the following side effects:
Diarrhea
Vomiting
Skin rash
Dizziness
Bitterness in mouth.

Monday, August 25, 2014

Nimesulide Analgesic action for pain relief

The efficacy and tolerability of Nimesulide in treatment of acute pain, osteoarthritis and primary dysmenorrhoea was consistently superior to placebo. Nimesulide drug for pain relief has a relatively rapid onset of the analgesic action for the patients suffering from acute pain which shows meaningful reductions observed within 15 minutes from drug intake. Nimesulide is a prescription-only drug and must be prescribed by a licensed physician after careful evaluation of the patient’s characteristics and needs. Nimesulide is available with the dosage of 100 mg for the tablets, and100 mg for granules for oral suspension, 200mg for the suppositories and 3% of gel. As for other NSAIDs the use of Nimesulide is preffered for the shortest duration necessary to control symptoms in patients with acute pain or primary dysmenorrhoea. The efficacy of Nimesulide was consistently superior to placebo with its particularly rapid onset action.

Tuesday, August 19, 2014

Nimesulide Tablets for acute pain, degenerative joint disease


Nimesulide is a pain killer NSAIDs drug for the Nimesulide brand, it is the best prescribed drug for treatment of acute pain, Primary dysmennorhea and also to treat degenerative joint disease.


Nimesulide drug was launched in Italy for the first time as Aulin and Mesulid in 1985 and is presently available in more than 50 countries worldwide with different trademarks.


It has superior gastrointestinal safety with its multifactorial approach and gives a rapid action pain relief. The maximum duration and dose of a treatment course with nimesulide is 15 days, 100 mg twice a day, to minimize the risk of hepatotoxicity.


Nimesulide is contraindicated in patients with gastrointestinal bleeding ulcer, hypersensitive, Kidney and liver diseases